312 results
Page 2 of 16
8-K
EX-99.1
3w20rd
8 Aug 23
Theriva™ Biologics Reports Second Quarter 2023 Operational Highlights and Financial Results
8:10am
8-K
EX-99.1
royy1jiw 65zw5g7e25b
2 Aug 23
Regulation FD Disclosure
9:22am
8-K
EX-99.1
le6ushd7yhtk ppv3
27 Jun 23
Theriva Biologics Announces Orphan Drug Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Pancreatic Cancer
5:11pm
8-K
EX-99.1
k1dl xqlj9f8e
11 May 23
Theriva Biologics Reports First Quarter 2023 Operational Highlights and Financial Results
8:10am
8-K
EX-99.1
6zygt2w05d9 qi3hppnl
30 Mar 23
Theriva Biologics Reports Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results
8:15am
8-K
EX-99.1
61ih5f3 ts
10 Nov 22
Theriva Biologics Reports Third Quarter 2022 Operational Highlights and Financial Results
5:11pm
8-K
EX-99.1
f7f69p
12 Oct 22
Amendments to Articles of Incorporation or Bylaws
8:15am
8-K
EX-99.1
f9r06jgcty
30 Sep 22
Regulation FD Disclosure
8:10am
8-K
EX-99.1
67rqthj6mssmnz0ozg
27 Sep 22
Regulation FD Disclosure
8:16am
424B3
yoeo4
16 Sep 22
Prospectus supplement
4:15pm
8-K
EX-99.1
lworf
6 Sep 22
Regulation FD Disclosure
8:10am